Introduction
Cells (chondrocytes) - 5%
ECM
- Fibers
-Elastins Ground substance
- H20 (75%) - Proteoglycans and glycosaminoglycans
- Glycoproteins
- Degradative enzymes (matrix metalloproteinases) - Extracellular ions
Structure
Layers
- decreasing H20, collagen, increasing PG from superficial to deep - I Superficial gliding zone: thinnest, collagen fibers parallel to resist shear; first to show OA - II Middle transitional zone: fibers obliquely; II and III have chondrons: communities of 2-3 chondrocytes - III radial zone: largest, resists load and distributes compression - tidemark - acellular; boundary between calcified and uncalcified cartilage - IV calcified zone: hydroxyapatite crystals, type X collagen
Collagen
- 90% type II - Type I not normally found, only following injury - Type X: associated with cartilage calcification
Proteoglycans and glycosaminoglycans
- responsible for most of the water content of cartilage - gives compressive strength - hydrophilic molecules - GAG (chondroitin sulphate, keratan sulphate) bound by sugar bonds to linear core of protein - Aggrecan is the predominant proteoglycan
Degradative Enzymes
- Matrix metalloproteinases
- Tissue-induced metalloproteinase inhibitors (TIMPs)
Ions
- high sodium and potassium ion - sulphate residues on PGs attract these ions - calcium high in calcified zone
Glycoproteins
- macromolecules: tissue glue - COMP –> binds to various matrix proteins - lubricin - joint lubricant
Chondrocytes
- from MSCs - articular and growth plate chondrocytes –> different terminal differentiation - diffusion for cell nutrition - joint loading important for nutrition
Function
- joint lubrication
- shock absorption
Biomechanical properties - creep - sress relaxation - anisotropic
Lubrication
- boundary lubrication - fluid film lubrication
Injury and healing
- superficial injuries (above tidemark) heal - deep injuries –> hematoma, fibrin clot/ inflammation –> fibrocartilage - infections –> hydrolysis of collagen and PGs, cells (–> release of lysosomal enzymes) - OA
Treatment
Non-operative
Physical therapy `````````````` - immobilization –> cartilage atrophy - Salter (1989): CPM –> FT defects in rabbits
Oral visco-supplementation `````````````````````` - Glucosamine
- Chondroitin
Intra-articular visco-supplmentation `````````````````````````````` - MW: Low (Hyalgan), intermediate (Orthovisc), HMW (Synvisc) - limited evidence - no good studies showing good results
Operative Treatment
Abrasion arthroplasty `````````````````` - turns cartilage defect into a 'deep injury' - fibrocartilage healing
Autograft/mosaicplasty ``````````````````` - full thickness osteochondral grafts from superomedial margin of femoral notch
- superceded by newer tissue engineering therapies
Allograft ```````` - mostly for malignant tumors - cartilage is immunoprivileged tissue - spore-forming organism infection
Periosteal/perichondrial mesenchymal stem cells
- cambium layer - type II collagen and high PGs seen in repair tissue - no convincing reports of efficacy
Chondrocytes from mesenchymal stem cells
- bMSC isolation –> 3D matrix –> defect
Autologous chondrocyte implantation (ACI)
- Brittberg (1994) - harvest –> ex vivo expansion –> collagen gel carrier - reinserted and periosteal flap sutured - newer MACI
Role of growth factors
- TGF, IGF-1, FGF –> chondrocyte proliferation - IGF-1 stimulate collagen and PG production - BMPs - limited success in human trials
Viva Questions
- What is the composition of articular cartilage? - Draw the structure of articular cartilage - How are the functions of articular cartilage? How is structure related to function? - What pathological processes are involved in the develop of osteoarthritis? - What are the different options available for treating cartilage defects?
Revisions 2013-02-12: Original notes transferred from Evernote